TuHURA Biosciences, Inc. (HURA) Research

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

Market snapshot

Symbol
HURA
Price
$2.57
Day change
+15.77%
Market cap
$163.7M
P/E ratio
-4.99x
52-week range
0.41-3.9
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Acumen Pharmaceuticals, Inc. (ABOS)
  • Agenus Inc. (AGEN)
  • Cognition Therapeutics, Inc. (CGTX)
  • Inovio Pharmaceuticals, Inc. (INO)
  • Opus Genetics, Inc. (IRD)
  • Seres Therapeutics, Inc. (MCRB)
  • Seer, Inc. (SEER)
  • Spero Therapeutics, Inc. (SPRO)

Recent insider activity

  • Bianco James A. — G-Gift (150000 shares) on 2026-05-28
  • Tendler Craig — A-Award (156240 shares) on 2026-02-12
  • Ng George K — A-Award (156240 shares) on 2026-02-12
  • MANUSO JAMES S J — A-Award (156240 shares) on 2026-02-12
  • List Alan — A-Award (156240 shares) on 2026-02-12

Open TuHURA Biosciences, Inc. (HURA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.